世界の注射剤市場は2020年に4,148億8,000万USドルになると評価されました。糖尿病、癌、関節リウマチや多発性硬化症などの自己免疫疾患などの疾患の有病率の増加と慢性疾患の数の急増により、ドラッグデリバリーシステムの必要性と注射剤の需要が高まっています。自己注射器、ペン型注射器、プレフィルドシリンジ（PFS）、無針注射器などの自己投与型注射剤の使用の増加により、注射剤の受け入れが進んでいます。
注射剤市場は、規制上の課題、価格圧力、特許失効、および医薬品の不足を特徴としています。高分子ペプチドやワクチンなどの複雑なセグメントでの主要な需要は、アメリカでの注射剤の不足と相まって、注射剤市場に大きなチャンスをもたらします。高分子注射剤市場は、今後数年間で急速に成長すると予測されています。高齢者人口の増加と糖尿病や癌などの慢性疾患の有病率の上昇は、市場を推進する重要な要因です。
北アメリカは、医療インフラの急速な発展、この地域における主要企業の存在、研究開発への巨額の投資、さまざまな癌を治療するための病院での腫瘍関連薬の採用の増加により、注射剤市場を支配しています。
アジア太平洋地域は、予測期間中に世界の注射剤市場で最も速い成長を記録すると予想されます。さらに、経口投与後の胃腸管からの適切な吸収を可能にするために、水溶性が低く、および／または透過性が非常に低い新製剤の数が増加しています。このような薬を体内に取り込むには、静脈内投与しかありません。
目次
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Injectable Drugs Market: Product Outlook
4. Global Injectable Drugs Market: Sizing and Forecast
4.1 Global Injectable Drugs Market Size, By Value, Year 2016-2026
5. Global Injectable Drugs Market Segmentation - By Product, By Molecule, By Delivery
5.1 Competitive Scenario of Global Injectable Drugs Market: By Product
5.1.1 Complex Biologics ñ Market Size and Forecast (2016-2026)
5.1.2 Conventional Therapeutics ñ Market Size and Forecast (2016-2026)
5.1.3 Vaccines ñ Market Size and Forecast (2016-2026)
5.1.4 Insulin ñ Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Injectable Drugs Market: By Molecule
5.2.1 Small Molecule ñ Market Size and Forecast (2016-2026)
5.2.2 Large Molecule ñ Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Injectable Drugs Market: By Delivery
5.3.1 Pre-filled Syringe ñ Market Size and Forecast (2016-2026)
5.3.2 Infusions - Market Size and Forecast (2016-2026)
5.3.3 Others ñ Market Size and Forecast (2016-2026)
6. Global Injectable Drugs Market: Regional Analysis
6.1 Competitive Scenario of Global Injectable Drugs Market: By Region
7. North America Injectable Drugs Market: An Analysis (2016-2026)
7.1 North America Injectable Drugs Market : Size and Forecast (2016-2026), By Value
7.2 North America Injectable Drugs Market ñ Prominent Companies
7.3 Market Segmentation By Product (Complex Biologics, Conventional Therapeutics, Vaccines and Insulin)
7.4 Market Segmentation By Molecule (Small Molecule and Large Molecule)
7.5 Market Segmentation By Delivery (Pre-filled Syringe, Infusions and Others)
7.6 North America Injectable Drugs Market: Country Analysis
7.7 Market Opportunity Chart of North America Injectable Drugs Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Injectable Drugs Market: By Country
7.9 United States Injectable Drugs Market: Size and Forecast (2016-2026), By Value
7.10 United States Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
7.11 Canada Injectable Drugs Market: Size and Forecast (2016-2026), By Value
7.12 Canada Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
8. Europe Injectable Drugs Market: An Analysis (2016-2026)
8.1 Europe Injectable Drugs Market: Size and Forecast (2016-2026), By Value
8.2 Europe Injectable Drugs Market - Prominent Companies
8.3 Market Segmentation By Product (Complex Biologics, Conventional Therapeutics, Vacccines, Insulin)
8.4 Market Segmentation By Molecule (Small Molecule and Large Molecule)
8.5 Market Segmentation By Delivery (Prefilled Syringe, Infusions and Others)
8.6 Europe Injectable Drugs Market: Country Analysis
8.7 Market Opportunity Chart of Europe Injectable Drugs Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Injectable Drugs Market: By Country
8.9 Germany Injectable Drugs Market: Size and Forecast (2016-2026), By Value
8.10 Germany Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
8.11 United Kingdom Injectable Drugs Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
8.13 France Injectable Drugs Market: Size and Forecast (2016-2026), By Value
8.14 France Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
8.15 Italy Injectable Drugs Market: Size and Forecast (2016-2026), By Value
8.16 Italy Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
9. Asia Pacific Injectable Drugs Market: An Analysis (2016-2026)
9.1 Asia Pacific Injectable Drugs Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Injectable Drugs Market - Prominent Companies
9.3 Market Segmentation By Product (Complex Biologics, Conventional Therapeutics, Vacccines, Insulin)
9.4 Market Segmentation By Molecule (Small Molecule and Large Molecule)
9.5 Market Segmentation By Delivery (Prefilled Syringe, Infusions, Others)
9.6 Asia Pacific Injectable Drugs Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Injectable Drugs Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Injectable Drugs Market: By Country
9.9 China Injectable Drugs Market: Size and Forecast (2016-2026), By Value
9.10 China Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
9.11 Japan Injectable Drugs Market: Size and Forecast (2016-2026), By Value
9.12 Japan Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
9.13 India Injectable Drugs Market: Size and Forecast (2016-2026), By Value
9.14 India Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
9.15 South Korea Injectable Drugs Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Injectable Drugs Market Segmentation - By Product, By Molecule and By Delivery (2016-2026)
10. Global Injectable Drugs Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Injectable Drugs Market - By Product, 2026
11.2 Market Attractiveness Chart of Global Injectable Drugs Market - By Molecule, 2026
11.3 Market Attractiveness Chart of Global Injectable Drugs Market - By Delivery, 2026
11.4 Market Attractiveness Chart of Global Injectable Drugs Market - By Region, 2026
12.Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. Regulatory Compliance
14. Company Analysis
14.1 Johnson & Johnson
14.2 Pfizer
14.3 GlaxoSmithKline
14.4 Novartis
14.5 Eli Lilly and Company
14.6 AstraZeneca Plc
14.7 Sanofi
14.8 Merck KGaA
14.9 Novo Nordisk
14.10 Baxter International
